• About CEIBS

    China Depth, Global Breadth

    CEIBS Beijing
    664
  • About CEIBS

    Unmatched China knowledge, proven global expertise

    CEIBS Shanghai
    664

CEIBS 14th Annual China Health Care Forum 2018

Deepening Healthcare System Reform to Build a Healthy China

Contact

Tel: 
Fax: 
+86-21-28905273
Post: 
699 Hongfeng Road, Shanghai 201206, PRC

Year 2018 will be crucial for China, as it marks not only the first year following the 19th National Congress of the CPC, but also the 40th anniversary of China’s reform and opening-up. Birth, ageing, sickness and death are major life events; therefore deepening reform of the medical and public healthcare system to provide people with affordable and easy access to quality medical services and improve their health and well-being is one of the many measures the Chinese government plans to enhance the lives of ordinary people. This is also consistent with the national strategy of developing a healthy China, as  a healthy population is key to the country’s future development. We now need to grapple with several thorny issues central to attaining the objectives outlined in the “Healthy China 2030” initiative: Along with continuous innovation and reform in the healthcare sector, how will we ensure synergy among medical insurance, medical services and medicine through integrated and coordinated efforts? How will the government, hospitals and pharmaceutical companies join hands and work on issues that are well known but hard to address in the health reform?

The new normal in the new era requires us to think outside the box. Over the past year, the Chinese government has taken a holistic, integrated and collaborative approach to reform in the medical insurance system, medical services, and production and distribution of pharmaceuticals, as exemplified by refinement of the medical care system, expansion of the pilot program, and IT-based management of medical data. In 2018, a new chapter begins in China’s healthcare system reform, as a move towards more integrative and proactive policies can be discerned. As we know, practice is a good touchstone for institutional reform. How can we carry out a top-level design of the medical insurance system to bring benefits to patients? How can we clear away institutional obstacles to public hospital reform and carry through reform in the pharmaceutical industry to increase the availability of innovative drugs to patients? Facing these critical issues, we still need to draw lessons from domestic and overseas success stories in healthcare system reform so as to chart a course to build a healthy China.

Under the theme of “Deepening Healthcare System Reform to Build a Healthy China”, CEIBS 14th China Health Care Forum – which consists of a main forum and sub-forums on medical insurance, hospitals and pharmaceuticals – will focus on how to put in place the policy framework for healthcare system reform to bring benefits to ordinary people. Government decision-makers, scholars and leaders in the health industry will share their views about healthcare system reform with stakeholders in the fields of medical insurance, medical services and medicine.

May 12 (Saturday)

08:30 ~ 09:00

Registration

Petrochemical Auditorium, CEIBS
Address: 699, Hongfeng Road, Pudong New Area, Shanghai

09:00 ~ 09:10

Welcome Address
Prof. Li Mingjun
President; Professor of Management, CEIBS

Session I: Healthcare System Reform: Progress and Trends

In 2018, a new chapter begins in China’s healthcare system reform, as a move towards more integrative and proactive policies can be discerned. With refinement of the medical care system, expansion of the pilot program, and IT-based management of medical data, a better policy framework has emerged. Nevertheless, the acid test for healthcare system reform will come when this policy framework is put into practice. What progress has been made in healthcare system reform? What should be done next? What challenges will we face? How can we ensure synergy between institutional innovation and practice? In this session, experts in healthcare system reform will present their views.

09:10 ~ 09:40

Keynote Speech (I)
Mr. Wu Jinglei, Director, Shanghai Municipal Commission of Health and Family Planning

9:40 ~ 10:10

Keynote Speech (II)
Mr. Ge Yanfeng, Director-General, Research Department of Social Development, Development Research Center of the State Council

10:10 ~ 10:30

Q&A
Moderator: Prof. John Cai 
Adjunct Professor of Economics; Director of CEIBS Centre for Health Care Management and Policy

10:30 ~ 11:00

Coffee Break

Session II: Medical Insurance System: Innovative Top-Level Design and Implementation

The recent government policies for healthcare system reform indicate that reform in the medical insurance system has become a significant driver of coordination among medical insurance, medical services and medicine and implementation of multi-tiered diagnosis and treatment. China’s medical insurance system is characterized by the urban-rural dual structure and the blurred line between managerial and operating functions, which constitute a stumbling block to deepening healthcare system reform. Therefore, the existing medical insurance system needs to be upgraded to “version 2.0”. Overall, China’s medical insurance system reform will aim to address the mismatch between medical insurance coverage and medical services and between medical insurance coverage and drug prices. How will we bring the medical insurance system into full play? What obstacles will we need to remove? What lessons can we draw from practice? What critical steps will we need to take to effect reform in the medical insurance system? How will we clarify the functions and relationships between social insurance and commercial insurance? In this session, officials from national and local medical insurance authorities will share their views, while scholars in medical insurance will provide their insights into innovation in commercial insurance.

11:00 ~ 11:15 Keynote Speech
Mr. Yan Qinghui, Deputy Director, Department of Medical Insurance, Ministry of Human Resources and Social Security

11:15 ~ 12:30

Panel Discussion
Moderator:
Mr. Jin Weigang: President, Chinese Academy of Labor and Social Security

Panelists:

  • Mr. Yan Qinghui, Deputy Director, Department of Medical Insurance, Ministry of Human Resources and Social Security
  • Mr. Wang Pingyang, Associate Counsel, Zhejiang Province Human Resources and Social Security Department
  • Mr. Que Guangchang, Deputy Director-General, Human Resources and Social Security Department of Guangdong Province
  • Ms. Cao Baiyan, Founder and CEO, Jianyi Tech; a UK/Chinese actuary

12:30 ~ 13:30

Lunch

Session III: Hospital Reform: Removing Institutional Obstacles

Public hospital reform lies at the heart of healthcare system reform. With the policy framework for public hospital reform in place, we will need to step up our efforts to scale up pilot programs, overhaul the government subsidy mechanism for public hospitals’ income, optimize the operations, HR and remuneration system of public hospitals, as well as rein in medical expenses and improve medical services. Medical partnership will be given priority in a move to promote multi-tiered diagnosis and treatment and improve the medical service system. How will public hospitals break away from the rigid system for operations, HR and brand extension to push forward healthcare system reform? What role will medical partnership play in the medical system? In this session, National Health and Family Planning Commission officials responsible for hospital management, along with overseas scholars, will explore the paths to overcoming institutional obstacles to a modern hospital management system. Public hospital presidents will also share their experience in establishing a modern hospital management system.

13:30 ~ 13:45 Keynote Speech
Mr. Zhang Zongjiu, Director-General, Bureau of Medical Administration, National Health Commission of the People’s Republic of China

13:45 ~ 15:00

Panel Discussion
Moderator:
Mr. Gao Jiechun, Director-General, Hospital Management Institute, Fudan University

Panelists:

  • Mr. Zhang Zongjiu, Director-General, Bureau of Medical Administration, National Health Commission of the People’s Republic of China
  • Ms. Qiu Fenglin, Deputy Inspector, Health and Family Planning Commission of Shandong Province
  • Mr. Zhang Wei, Party Chief, West China School of Medicine/West China Hospital of Sichuan University
  • Mr. Huang Dongsheng, President, Zhejiang Provincial People's Hospital
  • Prof. Ramakrishna S. Velamuri, Professor of Entrepreneurship; Chengwei Ventures Chair in Entrepreneurship, CEIBS

15:00 ~ 15:30

 Coffee Break

Session IV: Reform in the Pharmaceutical Industry: Increased Availability and Value Innovation

Technological innovation in the pharmaceutical industry, which requires continuous effort and considerable investment, is fraught with risk and uncertainty. Considering that China remains far behind developed countries in drug innovation, a raft of policies has been unveiled by the China Food and Drug Administration (CFDA) in recent years to boost drug development and improve generic drugs. They are making a great difference to China’s pharmaceutical industry. What will the CFDA need to do to increase the availability of innovative drugs? How will we safeguard innovative drugs after they hit the market? How will we create new patient service models through reform in the pharmaceutical industry? In this session, officials will elaborate on government policies to analyze the challenges and opportunities for reform in the pharmaceutical industry. Local government officials and overseas scholars will share global practices in drug innovation. Pharmaceutical companies will contribute their ideas about meeting the challenges for drug innovation and reform in the pharmaceutical industry. In addition, pharmaceutical distributors will offer advice on improving the drug distribution system to facilitate drug innovation.

15:30 ~ 15:45 Keynote Speech
Mr. Chen Kaixian, Academician, Chinese Academy of Sciences; Chair, Shanghai Association for Science and Technology; Research Fellow, Shanghai Institute of Materia Medica, Chinese Academy of Sciences

15:45 ~ 17:10

Panel Discussion
Moderator:
Mr. Tang Minhao, President, Shanghai Association of Food and Drug Safety

Panelists:

  • Mr. Chen Kaixian, Academician, Chinese Academy of Sciences; Chair, Shanghai Association for Science and Technology; Research Fellow, Shanghai Institute of Materia Medica, Chinese Academy of Sciences
  • Mr. Julio Gay-Ger, President and General Manager, Lilly China
  • Mr. Li Yongzhong, General Manager, Shanghai Pharmaceutical Co., Ltd.; Executive Director, Shanghai Pharmaceuticals Holding Co., Ltd.
  • Dr. Yang Qing, Executive Vice President, Chief Business Officer and Chief Strategy Officer, WuXi AppTec
  • Mr. Eric Bouteiller, Honorary Chairman, China Association of Enterprises with Foreign Investment R&D-based Pharmaceutical Association Committee

17:10 ~ 17:20

Closing Address
Prof. Pedro Nueno
President (European); Professor of Entrepreneurship, CEIBS

President and Professor of Management, CEIBS

Director, Shanghai Municipal Commission of Health and Family Planning

Director-General, Research Department of Social Development, Development Research Center of the State Council

Adjunct Professor of Economics; Director of CEIBS Centre for Health Care Management and Policy

Deputy Director, Department of Medical Insurance, Ministry of Human Resources and Social Security

President, Chinese Academy of Labor and Social Security

Associate Counsel, Zhejiang Province Human Resources and Social Security Department

Deputy Director-General, Human Resources and Social Security Department of Guangdong Province

Founder and CEO, Jianyi Tech; a UK/Chinese actuary

Director-General, Bureau of Medical Administration, National Health Commission of the People’s Republic of China

Director-General, Hospital Management Institute, Fudan University

Deputy Inspector, Health and Family Planning Commission of Shandong Province

Party Chief, West China School of Medicine/West China Hospital of Sichuan University

President, Zhejiang Provincial People's Hospital

Professor of Entrepreneurship; Chengwei Ventures Chair in Entrepreneurship, CEIBS

Academician, Chinese Academy of Sciences; Chair, Shanghai Association for Science and Technology; Research Fellow, Shanghai Institute of Materia Medica, Chinese Academy of Sciences

President, Shanghai Association of Food and Drug Safety

President and General Manager, Lilly China

General Manager, Shanghai Pharmaceutical Co., Ltd.; Executive Director, Shanghai Pharmaceuticals Holding Co., Ltd.

Executive Vice President, Chief Business Officer and Chief Strategy Officer, WuXi AppTec

Honorary Chairman, China Association of Enterprises with Foreign Investment R&D-based Pharmaceutical Association Committee

President (European); Professor of Entrepreneurship, CEIBS

Forum Organisers

China Europe International Business School

Organizers

CEIBS is a not-for-profit joint venture established in 1994 with the support of the Chinese government and the European Commission. Over the past two decades, CEIBS has made outstanding achievements and received wide recognition from the society, with its reputation as a prestigious business school in Asia being further strengthened and enhanced. With a vision to become the most respected international business school in the world, CEIBS is committed to educating socially responsible leaders versed in "China Depth, Global Breadth".

 

CEIBS Center for Healthcare Management and Policy

Organizers

The CEIBS Center for Healthcare Management and Policy was founded in 2010. It's mission is to be a window of CEIBS healthcare sector that provides services for students, faculty and alumni; to build an exchange and dialogue platform among academia, industry leaders and policy makers, facilitating development of innovation and management capability of the industry; and to be an important think tank in China's healthcare sector by sharing knowledge, information, experience, and the best practice in healthcare between China and the world, as well as providing healthcare policy advice. The research, teaching and events of Center focuses on the fields of industry innovation, health policy, and personal health management.

Conference Fee

Standard Fee:
RMB 6,800    USD 1,100

Note:

If you cancel at any time up to April 29, 2018, a prompt refund will be made to you upon receipt of your written notice (faxes are acceptable). A USD 110 (or RMB 700) non-refundable registration fee will be deducted from your payment. After that date no refunds will be made. If, for any reason, this conference is cancelled, we shall offer you a 100% refund of the conference fee. CEIBS shall not, however, be held responsible for covering airfares, hotel or other costs incurred by registrants. The fee includes attendance at all conference sessions and discussions, welcome banquet, luncheon, coffee breaks and full documentation. The fee does not include your travel or hotel expenses. Please note that we must receive your payment before the date of the conference.

Easy Ways to Register

  • If QR code does not work for you, please kindly register online by clicking here
  • E-mail:   healthcareforum@ceibs.edu
  • Inquiry Tel:  +86-21-28905356
  • Scan below QR code to register:
Conference Venue

The conference will take place at the Petrochemical Auditorium located at the China Europe International Business School's main campus in Shanghai.

Address: 699 Hongfeng Road, Pudong Shanghai, 201206, PRC

Map to China Europe International Business School

Accommodation

Marriott Hotel Pudong Shanghai
15 Xinjinqiao Rd., Pudong, Shanghai, China
www.marriott.com  Tel: 86-21-60368888
Deluxe Room RMB 712 (for reference)
* The price including a breakfast and 15% service fee

CEIBS Residence
699 Hongfeng Rd., Pudong, Shanghai, China
Guest Room RMB 380 (for reference) 
* The price including a breakfast and 15% service fee

Reservation
Please indicate that you are participating in the 11th Annual China Health Care Industry Forum organized by CEIBS. The discounted rate is effective on or before May 30. Reservations after this date will be taken on a space and rate availability basis.

Contact Us

For more details about the 14th Annual China Health Care Forum, please contact:

Ms. Jill Wang (Cooperation)
Marketing & Communications Department
Tel: +86-21-28905262  |  Email: wjill@ceibs.edu

Ms. Sophie Zhu (Registration)
Marketing & Communications Department
Tel: +86-21-28905305  |  Email: zsophie@ceibs.edu​

Ms. Sabrina Chu (Chinese Media)
Marketing & Communications Department
Tel: +86-21-28905071  |  Email: csabrina@ceibs.edu

Mr. David Yu (International Media)
Marketing & Communications Department
Tel: +86-21-28905073 | Email: ydavid@ceibs.edu

Address:
China Europe International Business School (CEIBS)
699 Hongfeng Road, Pudong, Shanghai 201206 P.R.C.
Tel: +86-21-28905890  | Fax: +86-21-28905678  |  Map